How promising is the idea of stem cells for MS? I have been working slowly as time permits on a piece more specifically about hematopoietic stem cell transplantation (HSCT) for MS. Two new pieces caught my eye on this topic so I’ll start with those. Stem cells for MS NurOwn Found Safe, Shows Promise in […]
Weekly reads: stem cells for MS, blood origins, iPSCs Read More »
Does aging do something to time so it seems like as you get older that time goes by faster? Remember as a little kid when summer seemed to last forever and car rides could be agonizingly long? I’ve heard two theories on this. One is that the brain’s baseline of activity slows down with aging
Weekly stem cell reads: aging & cells, iPS cell mutations, gut, more Read More »
When I first started this blog back in 2010 the most contentious issue on the more political side of our field was federal funding for embryonic stem cell research. It was something you couldn’t take for granted. Some history on embryonic stem cell funding in the US There were times back then when funding of
Is embryonic stem cell research a target after Roe? Read More »
A few people in the stem cell field keep arguing that adult pluripotent stem cells exist, including so-called “very small embryonic-like stem cells” or VSEL stem cells. These days the supposed cells are called VSELs or V-cells too. Only a handful of researchers have ever been able to report finding and studying these cells. Others
Fact-checking VSEL stem cells & VSEL treatment Read More »
Parabiosis refers to the joining together of two animals, typically rodents in research. They become one interconnected living system that shares blood. Research on mouse parabiosis has sparked much interest in anti-aging therapies. These might utilize “young” materials to help older people. Our first recommended read is a parabiosis paper. Before we jump into that,
Weekly stem cell reads: parabiosis, UC Davis trial, HeLa lawsuit, gray hair Read More »
Many of you readers know tech guru Peter Diamandis for his great X PRIZE, but he’s also involved in the regenerative medicine world including a new effort called Fountain Life. Teaming up with life coach Tony Robbins and others for Fountain Life raises some red flags for me. What’s in this article Peter Diamandis and
Review of Peter Diamandis Fountain Life clinics: more than stem cell hype? Read More »
It seems like the field of cell biology has mixed feelings about fibroblasts so I’m going to start off there with the recommended reads. But first, check out our stem cell YouTube channel as we are steadily heading toward 500 subscribers and 30,000 views. Please subscribe. I’ve pasted one of our top videos below, which
Weekly reads: fibroblasts, cancer stem cells, Parkinson’s Read More »
Sometimes a post here on The Niche (named after the stem cell niche) sparks a debate between expert stem cell researchers and often that gives much more depth to a topic. Such was the case with my post this week on where things stand with stem cell therapy for heart disease. It led to a
Weekly reads: Melton leaves Harvard, Fuji, BBC blunder, stem cell niche, more Read More »
It’s been quite a ride doing this blog on stem cells and other technologies for more than a dozen years. So far it seems like I’ll keep it going. A large part of the reason is because of people needing good information about our field. Those people include scientists and physicians but also many in
Weekly reads: Google, stem cells & MS, VSELs, ‘hairy’ organoids, MYC Read More »
A clinic called DVC Stem selling unproven stem cells has popped up prominently on the web recently. It’s a relatively new and in some ways puzzlingly dominant presence on the stem cell section of the Internet. We should pay attention to these kinds of changes on the web. They can impact many people’s healthcare choices,
Review of DVC Stem & marketing of unproven therapies Read More »